Life Chemicals is honored to cooperate with the Institut Pasteur de Lille to fight against the Covid-19 pandemic. The Company has recently provided 640 compounds from Anti-coronavirus Focused Screening Libraries to be tested on the SARS-CoV-2 3CL protease, essential to the coronavirus replication cycle, to identify its novel inhibitors. These Libraries have enabled extending chemical diversity of molecules tested on the protease.
Volodymyr Fetyukhin, Ph.D. (Founder and President of Life Chemicals), commented: “At times of an unprecedented global pandemic like this one, international research cooperation and support are of extreme importance. And Life Chemicals was prompt to act: our chemoinformatics team came out with a number of coronavirus-focused libraries aimed at facilitating the identification of potent and promising hit molecules in HTS drug discovery programs. We are more than happy to make this contribution to drug discovery projects against COVID-19 and are looking forward to receiving good news on first screening results.”
Moreover, to meet this compelling need for potent new antivirals against COVID-19, Life Chemicals has designed a set of small-molecule screening compound libraries focusing on SARS-CoV important targets:
- 2019-nCoV Main Protease (also called 3CLpro)
- 2019-nCoV Papain-like Protease
- human elongation factor 1-alpha (eEF1A)
For further information on the Coronavirus Screening Libraries, please, use the following link: https://lifechemicals.com/screening-libraries/targeted-and-focused-screening-libraries/coronavirus-screening-libraries